Top brokers name 3 ASX shares to buy next week

Brokers are feeling bullish on these ASX shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With most brokers taking a break over the holiday period, there haven't been many notes hitting the wires.

But never fear! Summarised below are three recent recommendations that remain very relevant today. Here's what brokers are saying about these ASX shares:

Broker written in white with a man drawing a yellow underline.

Image source: Getty Images

Allkem Ltd (ASX: AKE)

According to a note out of Citi, its analysts have a buy rating and $17.80 price target on this lithium miner's shares. While the broker suspects that lithium prices may have peaked amid slowing electric vehicle demand in China, it doesn't appear too concerned. This is due to Allkem locking in strong contracted prices. Combined with production growth, Citi remains positive on the company's outlook. The Allkem share price ended the week at $11.91.

Corporate Travel Management Ltd (ASX: CTD)

A note out of Macquarie reveals that its analysts have an outperform rating and $19.95 price target on this corporate travel specialist's shares. The broker acknowledges that industry data shows that corporate travel activity softened in the United States in November, putting Corporate Travel Management at risk of falling short of first half expectations. However, with its shares down heavily over the last 12 months and trading at an attractive level, the broker appears to believe this is more than priced in. The Corporate Travel Management share price was fetching $15.62 at Friday's close.

Xero Limited (ASX: XRO)

Analysts at Bell Potter have a buy rating and $97.90 price target on this cloud accounting platform provider's shares. According to the note, the broker has taken positives from the recent release of the first quarter update from rival Intuit (the owner of Quickbooks). Bell Potter notes that the update revealed softness in the Australian market for QuickBooks, which could bode well for Xero. In addition, it notes that Intuit commented that it believes that digitisation rather than macro remains the key driver for cloud accounting. This is likely to be a positive for Xero in the current economic environment. The Xero share price ended the week at $71.62.

Motley Fool contributor James Mickleboro has positions in Allkem and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Corporate Travel Management. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Broker says this ASX 200 stock could rocket 50%+ in 12 months

Bell Potter has good things to say about this stock.

Read more »

Broker Notes

2 ASX 200 stocks drawing fresh buy ratings this week 

These shares have solid upside.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »

Wlorker on a laptop on top of solar panels.
Broker Notes

Up 8%, should I buy the rebound in Origin Energy shares today?

A leading analyst provides his forecast for Origin Energy’s rebounding shares.

Read more »